<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Amendment of section 35.</title>
    <link>https://www.taxtmi.com/acts?id=15926</link>
    <description>The amendment substitutes the terminal date in clause (5) of section 35(2AB) to extend the period during which a company engaged in biotechnology or qualifying manufacturing may claim a deduction equal to two times expenditure on approved in house research and development facilities, excluding costs of land or building. The change takes effect from the commencement date and applies to subsequent assessment years, leaving eligibility criteria and exclusion of land and building costs unchanged.</description>
    <language>en-us</language>
    <pubDate>Fri, 16 Mar 2012 14:02:13 +0530</pubDate>
    <lastBuildDate>Fri, 16 Mar 2012 17:34:21 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=252599" rel="self" type="application/rss+xml"/>
    <item>
      <title>Amendment of section 35.</title>
      <link>https://www.taxtmi.com/acts?id=15926</link>
      <description>The amendment substitutes the terminal date in clause (5) of section 35(2AB) to extend the period during which a company engaged in biotechnology or qualifying manufacturing may claim a deduction equal to two times expenditure on approved in house research and development facilities, excluding costs of land or building. The change takes effect from the commencement date and applies to subsequent assessment years, leaving eligibility criteria and exclusion of land and building costs unchanged.</description>
      <category>Act-Rules</category>
      <law>Bills</law>
      <pubDate>Fri, 16 Mar 2012 14:02:13 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/acts?id=15926</guid>
    </item>
  </channel>
</rss>